Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma.

Stijn FranssenJessica J HolsterJoshua S JolissaintLynn E NooijenAndrea CercekMichael I D'AngelicaMarjolein Y V HomsAlice C WeiVinod P BalachandranJeffrey A DrebinJames J HardingNancy E KemenyT Peter KinghamHeinz-Josef KlümpenBianca MostertRutger-Jan SwijnenburgKevin C SoaresWilliam R JarnaginBas Groot Koerkamp

Published in: Annals of surgical oncology (2023)

This study confirmed the results from the ABC trials that survival beyond 3 years is rare for patients with liver-confined unresectable iCCA treated with palliative gem-cis alone. With HAIP chemotherapy, one in three patients was alive at 3 years.

Keyphrases

locally advanced
rectal cancer
end stage renal disease
newly diagnosed
squamous cell carcinoma
ejection fraction
radiation therapy
chronic kidney disease
low dose
liver metastases
peritoneal dialysis
patient reported outcomes
advanced cancer